INTERPLAY OF HORMONAL PARAMETERS & IL – 6: OBESE VS NON-OBESE PCOS
-
Published:2022-12-01
Issue:
Volume:
Page:13-15
-
ISSN:
-
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
-
language:en
-
Short-container-title:ijsr
Author:
Kumar Dey Bishal1, Das Arun2, Ganguly Sarmishtha3, Chakraborty Somajita4, Roy Sanchita5
Affiliation:
1. Junior Research Fellow, Dept. of Anatomy, Diamond Harbour Govt. Medical College and Hospital 2. Demonstrator, Dept. of Biochemistry, Diamond Harbour Govt. Medical College and Hospital 3. Associate Professor, Dept. of Biochemistry, Diamond Harbour Govt. Medical College and Hospital 4. Professor and Head, Dept. of Obstetrics & Gynaecology, Diamond Harbour Govt. Medical College and Hospital 5. Associate Professor, Dept. of Anatomy, Diamond Harbour Govt. Medical College and Hospital
Abstract
Background: Polycystic Ovary Syndrome, the most common endocrinological disorder among women in the reproductive age group which is
characterized by chronic ovulatory dysfunction, certain hormonal disturbances as well as metabolic derangements. Aim: This study aimed to see a
correlation between Luteinizing Hormone and Interleukine – 6 level in normal and high body mass index women with PCOS and to establish the
importance of IL – 6 as a useful biomarker for predicting detrimental consequences of PCOS like the development of type 2 diabetes mellitus.
Methods: Follicle stimulating hormone, Luteinizing hormone, Thyroid stimulating hormone and Interleukine - 6 have been estimated. Statistical
analysis has been performed with SPSS software. Student's T-test is used to compare means between each of the test group with the control group
and Karl Pearson's method of correlation is used to nd out the correlation coefcient. Results: The study included 187 women, diagnosed with
PCOS (normal BMI group: n = 25, and high BMI group: n = 31) and 100 age matched control. There were signicant association found between LH
and IL – 6 concentrations in these two groups of PCOS with respect to control. Conclusion: There is an association in between IL – 6 and LH
concentrations in these two groups of PCOS with respect to control. IL – 6 is a marker for T2DM and the development of T2DM does not depends
on BMI. Probably, LH in its elevated condition play a vital role to develop T2DM in females with PCOS.
Publisher
World Wide Journals
Subject
Visual Arts and Performing Arts,Communication,Energy Engineering and Power Technology,Renewable Energy, Sustainability and the Environment,Electrical and Electronic Engineering,Computer Science Applications,Mechanical Engineering,Transportation,Cardiology and Cardiovascular Medicine,Molecular Biology,Molecular Biology,Structural Biology,Catalysis,General Engineering,Physical and Theoretical Chemistry,Process Chemistry and Technology,Catalysis,Process Chemistry and Technology,Biochemistry,Bioengineering,Catalysis,Cell Biology,Genetics,Molecular Biology,General Medicine
Reference25 articles.
1. Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E. M., Shawki, H. E.-D., & Amer, S. (2021). The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 22(5). https://doi.org/10.3390/ijms22052734 2. Ali, E. T., Jabbar, A. S., & Mohammed, A. N. (2019). A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia. Anemia, 2019. https://doi.org/10.1155/2019/3457347 3. Alnakash, A. H., & Al-Tae’e, N. K. (2007). Polycystic ovarian syndrome: The correlation between the LH/FSH ratio and disease manifestations. Middle East Fertility Society Journal, 12(1), 35–40. 4. Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003). Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update, 9(6), 505–514. https://doi.org/10.1093/humupd/dmg044 5. Dahiya, K., Sachdeva, A., Singh, V., Dahiya, P., Singh, R., Dhankhar, R., Ghalaut, P., & Malik, I. (2012). Reproductive hormone and thyroid hormone profile in polycystic ovarian syndrome.
|
|